Viewing Study NCT02444832


Ignite Creation Date: 2025-12-24 @ 9:27 PM
Ignite Modification Date: 2025-12-28 @ 12:37 AM
Study NCT ID: NCT02444832
Status: UNKNOWN
Last Update Posted: 2015-05-15
First Post: 2015-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy
Sponsor: Hospital Clinic of Barcelona
Organization:

Study Overview

Official Title: Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy
Status: UNKNOWN
Status Verified Date: 2015-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MACAARET
Brief Summary: Based on the anatomical features of the anterior Communicating artery complex, the investigators will analyze the outcome of the ACoA aneurysms treated by endovascular therapy.

The most common site of intracranial aneurysms is the anterior communicating artery (AcomA). AcomA aneurysms account for approximately one-fourth of all intracranial aneurysms.

Recent publications have addressed specifically the endovascular treatment of AcoA aneurysms. Furthermore, detailed anatomic characteristics and the effects of the multiple variations of the anterior communicating artery complex have scarcely been reported.

The hemodynamic factors play a fundamental role in the adequate treatment of aneurismal coiling.

The objective of our registry is to analyze the impact of morphological configuration of the anterior communicating artery complex and the results of coil embolization in AcoA aneurysms
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: